Depression, anxiety, and suicidality in patients with prostate cancer: a systematic review and meta-analysis of observational studies
The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
Background Psychiatric implications of prostate cancer are increasingly recognised, having important effects on oncological and functional outcomes. However, findings for co-occurring depression, anxiety, and suicidality remain variable. Therefore, this review of observational studies aimed to establish best estimates of the prevalence and rates of these outcomes in prostate cancer patients.Methods A systematic literature search was conducted using MEDLINE, Scopus, PsycInfo, and Cochrane Library databases from inception up to 26 May 2020. Observational studies using validated methods for evaluating prevalences of depression, anxiety and suicidal ideation, or suicide mortality rates post prostate cancer diagnosis were included. Random effect models were used to calculate pooled prevalences of depressive and anxiety symptoms or disorders, and suicidal ideation post diagnosis. Additionally, pooled crude suicide mortality rates per 100,000 person years were calculated. Heterogeneity was explored using a stratified analysis.Results Of 3537 articles screened, 117 were included. Pooled prevalence for depressive disorders was 5.81% (95% CI 4.36-7.46) in 11 studies, representing 655,149 patients. Significant depressive symptoms were identified in 17.07% (15.14-19.09) across 32,339 patients and 76 studies. In total, 16.86% (14.92-18.89) had significant anxiety symptoms in 56 studies combining 24,526 patients. In 6,173 patients and eight studies, recent suicidal ideation was present in 9.85% (7.31-12.70). Crude suicide mortality rate after diagnosis was 47.1 (39.85-54.96) per 100,000 person years in 12 studies. Significant heterogeneity was seen with potential sources identified through our sensitivity analysis including diagnostic method utilised, study size and location of study.Conclusions The mental health impact in patients with prostate cancer is significant. Depressive, anxiety, and suicidal symptoms were common. Additionally, a high suicide mortality rate was identified when compared to general population estimates. Screening of patients and integration of physical and mental health care should be evaluated further to improve quality of life and functional outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“only few meta-analyses examined suicide risk among patients with cancer and those studies lacked a comprehensive literature search, generated incomplete findings regarding certain risk groups and/or analyzed only specific cancer entities, and/or presented only incidence rates without comparisons with the general population 24-29 .”
From Suicide risk and mortality among patients with cancer (2022) · cites this paper as [26]
In the citing paper
“An increased overall risk for suicide mortality in patients with cancer compared with the general population was consistently observed in those studies.”
From Suicide risk and mortality among patients with cancer (2022) · cites this paper as [26]
In the citing paper
“Our results in cancer patients do not mirror the higher suicide rates among men than women observed in the general population 26 because the increased baseline risk for suicide among men in the general population was accounted for by our SMR calculation.”
From Suicide risk and mortality among patients with cancer (2022) · cites this paper as [26]
In the citing paper
“our study covered more time, which led to the inclusion of at least four additional studies compared with the most recent previous study 26 .”
From Suicide risk and mortality among patients with cancer (2022) · cites this paper as [26]
In the citing paper
“including only 22 (ref. 25 ), 19 (ref. 24 ), 36 (ref. 26 ), 5 (ref. 27 ), 12 (ref. 28 ) and 5 (ref. 29 ) studies”
From Suicide risk and mortality among patients with cancer (2022) · cites this paper as [26]
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Hoy, D., Brooks, P., Woolf, A., Blyth, F., March, L., Bain, C., Baker, P., Smith, E., & Buchbinder, R. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.11.014 · Cited by 2,555
Metaprop: a Stata command to perform meta-analysis of binomial data
Nyaga, V. N., Arbyn, M., & Aerts, M. (2014) · Archives of Public Health · doi:10.1186/2049-3258-72-39 · Cited by 2,139
De Angelis, R., Sant, M., Coleman, M. P., Francisci, S., Baili, P., Pierannunzio, D., Trama, A., Visser, O., Brenner, H., Ardanaz, E., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70546-1 · Cited by 1,890
Prevalence of Depression in the Community from 30 Countries between 1994 and 2014
Lim, G. Y., Tam, W. W., Lu, Y., Ho, C. S., Zhang, M. W., & Ho, R. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-21243-x · Cited by 1,557
Krebber, A. M. H., Buffart, L. M., Kleijn, G., Riepma, I. C., de Bree, R., Leemans, C. R., Becker, A., Brug, J., van Straten, A., Cuijpers, P., et al. (2014) · Psycho-Oncology · doi:10.1002/pon.3409 · Cited by 908
Cited by
Suicide risk and mortality among patients with cancer
Heinrich, M., Hofmann, L., Baurecht, H., Kreuzer, P. M., Knüttel, H., Leitzmann, M. F., & Seliger, C. (2022) · Nature Medicine · doi:10.1038/s41591-022-01745-y · Cited by 136
“Brunckhorst et al. 26 and Guo et al. 27 limited their analyses to prostate and bladder cancer, respectively.”
Getie, A., Ayalneh, M., & Bimerew, M. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06599-5 · Cited by 117
“…in this review were general cancer patients [1, 7, 23, 24, 29, 31, 33, 41– 44], digestive tract cancer patients [6, 22], breast cancer patients [28, 35–40], prostate cancer patients [25, 26], liver cancer patients [30], ovarian cancer patients [27, 34], and cancer patients during COVID-19 [32].”
Ilie, G., Rendon, R., Mason, R. J., MacDonald, C., Kucharczyk, M. J., Patil, N., Bowes, D., Bailly, G. G., Bell, D., Lawen, J., et al. (2023) · European Urology · doi:10.1016/j.eururo.2023.02.009 · Cited by 65
“[6].”
BackgroundFear of cancer recurrence and PSA anxiety in patients with prostate cancer: a systematic review
James, C., Brunckhorst, O., Eymech, O., Stewart, R. J., Dasgupta, P., & Ahmed, K. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-06876-z · Cited by 53
Self-citationAnxiety, depression and urological cancer outcomes: A systematic review
Dinesh, A. A., Pinto, S. H. P. S., Brunckhorst, O., Dasgupta, P., & Ahmed, K. (2021) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2021.08.003 · Cited by 53
Self-citation
Metadata
- Authors
- Brunckhorst, O., Hashemi, S., Martin, A., George, G., Van Hemelrijck, M., Dasgupta, P., Stewart, R., & Ahmed, K.
- Affiliations
- Guy's Hospital (GB)
- King's College London (GB)
- Corresponding author
- Brunckhorst, Oliver
- Venue
- Prostate Cancer and Prostatic Diseases
- Published
- 2020-09-25
- Volume
- 24
- Issue
- 2
- Pages
- 281-289
- ISSN
- 1365-7852 (ISSN-L)
- 1476-5608
- OpenAlex
- W3088239633
- Cited by
- 116
- References
- 34
- Citations by year
- 2026: 13 · 2025: 25 · 2024: 25 · 2023: 25 · 2022: 19 · 2021: 8 · 2020: 1
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Prostate Cancer and Prostatic Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- RCUK | Medical Research Council
- King's Medical Research Trust
- Guy's and St Thomas' Charity
- King's Medical Research Trust King’s College London-Vattikuti Institute of Robotic Surgery
- DH | National Institute for Health Research
- Royal College of Surgeons of England
- Pelican Cancer Foundation
- King's Medical Research Trust, The Urology Foundation, Coptcoat Charity
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- prostate cancer, depression, anxiety, suicidal ideation, suicide mortality, psychiatric comorbidity, prevalence, mental health screening
- MeSH terms
- Anxiety, Depression, Humans, Male, Prostatic Neoplasms, Quality of Life, Suicide, Prevalence, Suicidal Ideation, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Depression, anxiety, and suicidality in patients with prostate cancer: a systematic review and meta-analysis of observational studies. https://app.cochat.ai/papers/10.1038/s41391-020-00286-0
- The paper
- Brunckhorst, O., Hashemi, S., Martin, A., George, G., Van Hemelrijck, M., Dasgupta, P., Stewart, R., & Ahmed, K. (2021). Depression, anxiety, and suicidality in patients with prostate cancer: a systematic review and meta-analysis of observational studies. Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-020-00286-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.